Treating Afib during cardiac surgery isn’t just recommended—it has Class I support. Yet it’s still
often skipped. Addressing Afib at the time of surgery can make a big difference in long-term outcomes.​

Find out why it matters at <a href="https://okt.to/7nTkdO&quot; target="_blank">https://okt.to/7nTkdO</a&gt;

<a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=CardiacSurgery&highligh…; target='_blank'>#CardiacSurgery</a>

Treating Afib during cardiac surgery isn’t just recommended—it has Class I support. Yet it’s still
often skipped. Addressing Afib at the time of surgery can make a big difference in long-term outcomes.​

Learn more at <a href="https://t.co/yRVO8etTN5&quot; target="_blank">https://t.co/yRVO8etTN5</a&gt;

<a href="https://twitter.com/hashtag/Afib?src=hashtag_click&quot; target="_blank">#Afib</a> <a href="https://twitter.com/hashtag/CardioTwitter?src=hashtag_click&quot; target="_blank">#CardioTwitter</a>

The Advancing Health Gallery at the Cincinnati Museum Center continues to ignite curiosity and deepen understanding of the human body through its interactive exhibits. AtriCure is proud to support the CMC’s heart exhibit and lead an annual outreach series including exhibit days and summer camps that deliver hands-on learning experiences designed to educate, empower and inspire the next generation of innovators. <a href='https://www.linkedin.com/feed/hashtag/?keywords=STEM&highlightedUpdateU…; target='_blank'>#STEM</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Innovation&highlightedU…; target='_blank'>#Innovation</a>

The Advancing Health Gallery at the Cincinnati Museum Center continues to ignite curiosity and deepen understanding of the human body through its interactive exhibits. AtriCure is proud to support the CMC’s heart exhibit and lead an annual outreach series including exhibit days and summer camps that deliver hands-on learning experiences designed to educate, empower and inspire the next generation of innovators. <a href="https://www.facebook.com/hashtag/STEM&quot; target="_blank">#STEM</a> <a href="https://www.facebook.com/hashtag/Innovation&quot; target="_blank">#Innovation</a>

Fast. Focused. Efficient.

The cryoSPHERE® MAX delivers targeted cryoablation in just 60 seconds, providing a quick and effective solution for post-operative pain management. Surgeons can help patients trade pain for numbness and support a smoother recovery.

Discover how:

Fast. Focused. Efficient.

The cryoSPHERE® MAX delivers targeted cryoablation in just 60 seconds, providing a quick and effective solution for post-operative pain management. Surgeons can help patients trade pain for numbness and support a smoother recovery.

Discover how: <a href="https://okt.to/a7Oprj&quot; target="_blank">https://okt.to/a7Oprj</a&gt;

<a href='https://www.linkedin.com/feed/hashtag/?keywords=PainManagement&highligh…; target='_blank'>#PainManagement</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=cryoNB&highlightedUpdat…; target='_blank'>#cryoNB</a>

“It’s crucial.”
Listen as Dr. Umaña shares why more surgeons should be treating Afib during cardiac surgery. With rising Afib rates, surgical ablation and LAA Exclusion can play a key role in reducing associated risks like stroke and heart failure.

Learn more at

“It’s crucial.”

Listen as Dr. Umaña shares why more surgeons should be treating Afib during cardiac surgery. With rising Afib rates, surgical ablation and LAA Exclusion can play a key role in reducing associated risks like stroke, heart failure and long-term complications.

Learn more at <a href="https://okt.to/w0BcHI&quot; target="_blank">https://okt.to/w0BcHI</a&gt;

<a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=CardiacSurgery&highligh…; target='_blank'>#CardiacSurgery</a>

For those who are symptomatic and unable to tolerate medications, the HEAL-IST Trial is
now enrolling. ​

The HEAL-IST Trial will evaluate the safety &amp; effectiveness of a hybrid sinus node-sparing ablation procedure. Learn more: <a href="https://t.co/GctEkS7k6a&quot; target="_blank">https://t.co/GctEkS7k6a</a&gt;

Over 3 million people in the U.S. live with Inappropriate Sinus Tachycardia (IST).​ For
those who are symptomatic and unable to tolerate medications, the HEAL-IST Trial is now enrolling. ​

This clinical study is evaluating the safety and effectiveness of a hybrid sinus node-sparing ablation
procedure as a potential treatment option. Learn more about the trial and patient qualifications at: HEAL- IST.com​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=InappropriateSinusTachy…; target='_blank'>#InappropriateSinusTachycardia</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=IST&highlightedUpdateUr…; target='_blank'>#IST</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=ClinicalTrial&highlight…; target='_blank'>#ClinicalTrial</a>​